Both in Biotechnology
4D Molecular Therapeutics vs Candel Therapeutics
Over the past year FDMT returned +3.5% and CADL returned +54.8%; their daily moves had a correlation of 0.46.
FDMT +3.5% CADL +54.8%Growth of $1, one year, split-adjusted
| Metric | FDMT | CADL |
|---|---|---|
| Price | $11.90 | $8.33 |
| Market cap | $657.4M | $637.4M |
| Today | −6.89% | −3.70% |
| 1 month | −14.0% | −18.0% |
| 6 months | +30.9% | +28.7% |
| Year to date | +58.7% | +47.4% |
| 1 year | +4.3% | +51.7% |
| Revenue growth (YoY) | +25106.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −1929.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 7.1× | — |
| Net cash | $341.7M | $153.7M |
| Dividend yield | — | — |
| Volatility (60d) | 75.3% | 65.1% |
| Short % of float | 21.6% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).